Approval recommended for raltegravir in experienced patients.
D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009930:Organic Chemicals / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D014481:United States; D014486:United States Food and Drug Administration
D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium